RxDoctor Payments Data

Sharon Ross, MD

Obstetrics & Gynecology · West Palm Beach, FLNPI 1518966639

Payments from drug & device makers

$2,174in general payments, 2019–2025

Across 105 payments — averaging $20.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$405
  • Exact Sciences$232
  • Astellas Pharma US Inc$205
  • Hologic Sales And Service, LLC$150
  • Pfizer$146
  • Axonics, Inc.$141
  • plus $894 from 17 others

What the payments were for

  • Food & beverage$2,13398%
  • Education$412%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,174 in reported general payments places this provider in the 70th percentile of 2,438 obstetrics & gynecology providers in Florida.

See all obstetrics & gynecology providers in Florida

Medicare billing

Part B allowed, 2024
$81,140
Medicare patients
535
Services billed
1,312

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol281$22,621
PremarinEstrogens, Conjugated41$16,411
YuvafemEstradiol35$6,881
Estradiol (Twice Weekly)Estradiol32$5,556
ValacyclovirValacyclovir Hcl72$4,047
ProgesteroneProgesterone, Micronized93$2,780
DottiEstradiol12$2,443
Metronidazole21$1,309
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip91$1,235
Clobetasol Propionate23$880
Estradiol (Once Weekly)Estradiol15$808
Fluconazole78$672
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst43$501
Alendronate Sodium81$459
Terconazole12$261

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$146$16,41141 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,438 obstetrics & gynecology providers in Florida.

Other obstetrics & gynecology in West Palm Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →